\
&
Contact us
\
&
Contact us
Published on | 1 day ago
Programmes MSCAThis factsheet lists the 5 main Marie Sklodowska-Curie Actions and impact on the careers of researchers. With a budget of €6.6 billion for the period 2021-2027, the Marie Sklodowska-Curie Actions (MSCA) is a research and training programme that supports the career, skills development, and mobility of researchers at all stages of their careers and from all over the world. The programme funds bottom-up research in all fields based on scientific excellence and competitive funding. The programme was named after the double Nobel Prize winner Marie Skłodowska-Curie to honour and spread the values she stood for. To date, more than 150 000 researchers have participated in the programme with many more benefiting from it – including 23 Nobel laureates.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
